Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Fig. 1

LNCAROD is highly expressed in HCC tissue and associated with a poor prognosis. A Gene expression of LNCAROD in human HCC compared with normal tissues from TCGA data sets. B LNCAROD expression in HCC tissues compared with paired adjacent normal tissues in HCC patients. C LNCAROD expression in HCC cell lines compared with THLE2 cells. D Kaplan-Meier analyses for the correlation between the LNCAROD level and overall survival in 92 HCC patients. The median was set as the cutoff point to differentiate high or low expression of LNCAROD. Data are shown as the mean ± SD. **P < 0.01

Back to article page